Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2012

Open Access 01-12-2012 | Research article

The cost-effectiveness of tracking newborns with bilateral hearing impairment in Bavaria: a decision-analytic model

Authors: Astrid Langer, Inken Brockow, Uta Nennstiel-Ratzel, Petra Menn

Published in: BMC Health Services Research | Issue 1/2012

Login to get access

Abstract

Background

Although several countries, including Germany, have established newborn hearing screening programmes for early detection and treatment of newborns with hearing impairments, nationwide tracking systems for follow-up of newborns with positive test results until diagnosis of hearing impairment have often not been implemented. However, a recent study on universal newborn hearing screening in Bavaria showed that, in a high proportion of newborns, early diagnosis was only possible with the use of a tracking system. The aim of this study was, therefore, to assess the cost-effectiveness of tracking newborns with bilateral hearing impairment in Bavaria.

Methods

Data from a Bavarian pilot project on newborn hearing screening and Bavarian newborn hearing screening facilities were used to assess the cost-effectiveness of the inclusion of a tracking system within a newborn hearing screening programme. A model-based cost-effectiveness analysis was conducted. The time horizon of the model was limited to the newborn hearing screening programme. Costs of the initial hearing screening test and subsequent tests were included, as well as costs of diagnosis and costs of tracking. The outcome measure of the economic analysis was the cost per case of bilateral hearing impairment detected. In order to reflect uncertainty, deterministic and probabilistic sensitivity analyses were performed.

Results

The incremental cost-effectiveness ratio of tracking vs. no tracking was €1,697 per additional case of bilateral hearing impairment detected.

Conclusions

Compared with no tracking, tracking resulted in more cases of bilateral hearing impairment detected as well as higher costs. If society is willing to pay at least €1,697 per additional case of bilateral hearing impairment detected, tracking can be recommended.
Appendix
Available only for authorised users
Literature
1.
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen: [Newborn hearing screening in the detection of hearing impairment]. 2007, Köln: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
2.
Wolff R, Hommerich J, Riemsma R, Antes G, Lange S, Kleijnen J: Hearing screening in newborns: systematic review of accuracy, effectiveness, and effects of interventions after screening. Arch Dis Child. 2010, 95 (2): 130-135. 10.1136/adc.2008.151092.CrossRefPubMed
3.
Pimperton H, Kennedy CR: The impact of early identification of permanent childhood hearing impairment on speech and language outcomes. Arch Dis Child. 2012, 97 (7): 648-653. 10.1136/archdischild-2011-301501.CrossRefPubMed
4.
Bundesausschuss Gemeinsamer: Bekanntmachung eines beschlusses des gemeinsamen bundesausschusses über eine änderung der kinder-richtlinien: einführung eines neugeborenen-hörscreenings. Vom 19. Juni 2008. Bundesanzeiger. 2008, 146: 3484.
5.
Rohlfs AK, Wiesner T, Drews H, Muller F, Breitfuss A, Schiller R, Hess M: Interdisciplinary approach to design, performance, and quality management in a multicenter newborn hearing screening project. Discussion of the results of newborn hearing screening in Hamburg (part II). Eur J Pediatr. 2010, 169 (12): 1453-1463. 10.1007/s00431-010-1229-0.CrossRefPubMed
6.
7.
Brockow I, Kummer P, Liebl B, Nennstiel-Ratzel U: [Universal newborn hearing screening (UNHS): is it possible to successfully implement it nationwide?]. Gesundheitswesen. 2011, 73: 477-482.CrossRefPubMed
8.
Nennstiel-Ratzel U, Brockow I, Wildner M, Koch-Dlouhy E, Gantner V, Schneider I, Strutz J, Richter E, Von Kries R: Neugeborenen-Hörscreening: Abschlussbericht zum Modellprojekt in der Oberpfalz und in Oberfranken. 2009, Erlangen: Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit
9.
Boshuizen HC, van der Lem GJ, Kauffman-de Boer MA, van Zanten GA, Oudesluys-Murphy AM, Verkerk PH: Costs of different strategies for neonatal hearing screening: a modelling approach. Arch Dis Child Fetal Neonatal Ed. 2001, 85 (3): F177-F181. 10.1136/fn.85.3.F177.CrossRefPubMedPubMedCentral
10.
Philips Z, Bojke L, Sculpher M, Claxton K, Golder S: Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics. 2006, 24 (4): 355-371. 10.2165/00019053-200624040-00006.CrossRefPubMed
11.
Akehurst R, Anderson P, Brazier J, Brennan A, Briggs A, Buxton M, Cairns J, Calvert N, Claxton K, Dixon S, et al: Decision analytic modelling in the economic evaluation of health technologies - a consensus statement. Pharmacoeconomics. 2000, 17 (5): 443-444. 10.2165/00019053-200017050-00003.CrossRef
12.
Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR: Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices–Modeling Studies. Value Health. 2003, 6 (1): 9-17. 10.1046/j.1524-4733.2003.00234.x.CrossRefPubMed
13.
Weinstein MC, Toy EL, Sandberg EA, Neumann PJ, Evans JS, Kuntz KM, Graham JD, Hammitt JK: Modeling for health care and other policy decisions: uses, roles, and validity. Value Health. 2001, 4 (5): 348-361. 10.1046/j.1524-4733.2001.45061.x.CrossRefPubMed
14.
Sculpher M, Fenwick E, Claxton K: Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application. Pharmacoeconomics. 2000, 17 (5): 461-477. 10.2165/00019053-200017050-00005.CrossRefPubMed
15.
Soto J: Health economic evaluations using decision analytic modeling. Principles and practices--utilization of a checklist to their development and appraisal. Int J Technol Assess Health Care. 2002, 18 (1): 94-111.PubMed
16.
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen: Arbeitspapier Modellierung. Version 1.0 vom 12.10.2009. 2009, Köln: IQWIG
17.
Briggs A, Claxton K, Sculpher M: Decision Modelling for Health Economic Evaluation. 2006, Oxford: Oxford University Press
18.
Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL: Methods for the economic evaluation of health care programmes. 2005, New York: Oxford University Press, 3
19.
Bamford J, Fortnum H, Bristow K, Smith J, Vamvakas G, Davies L, Taylor R, Watkin P, Fonseca S, Davis A, et al: Current practice, accuracy, effectiveness and cost-effectiveness of the school entry hearing screen. Health Technol Assess. 2007, 11 (32): 1-168. iii-ivCrossRefPubMed
20.
Kezirian EJ, White KR, Yueh B, Sullivan SD: Cost and cost-effectiveness of universal screening for hearing loss in newborns. Otolaryngol Head Neck Surg. 2001, 124 (4): 359-367. 10.1067/mhn.2001.113945.CrossRefPubMed
21.
Merlin T, Hedayati H, Sullivan T, Buckley E, Newton S, Hodgkinson B, Bywood P, Jenner F, Moss J, Hiller JE: Universal neonatal hearing screening. MSAC reference 17 Assessment report. 2007, Canberra: MSAC
22.
Deutsche Krankenhausgesellschaft: DKG-NT Band I: Tarif der Deutschen Krankenhausgesellschaft für die Abrechnung erbrachter Leistungen und für die Kostenerstattung vom Arzt an das Krankenhaus zugleich BG-T vereinbarter Tarif für die Abrechnung mit den gesetzlichen Unfallversicherungsträgern, vol. 31., überarbeitete Auflage. 2007, Berlin: Deutsche Krankenhausgesellschaft
23.
Kassenärztliche Bundesvereinigung: Einheitlicher Bewertungsmaßstab (EBM): Stand: 4. Quartal 2011. 2010, Berlin: Kassenärztliche Bundesvereinigung
24.
Böttcher P, Gramss M, Euler HA, Neumann K: [Cost analysis of a universal newborn hearing screening for clinics using the State of Hesse as an example]. HNO. 2009, 57 (1): 21-28. 10.1007/s00106-008-1879-7.CrossRefPubMed
25.
Colgan S, Gold L, Wirth K, Ching T, Poulakis Z, Rickards F, Wake M: The cost-effectiveness of universal newborn screening for bilateral permanent congenital hearing impariment: systematic review. Acad Pediatr. 2012, 12 (3): 171-180. 10.1016/j.acap.2012.02.002.CrossRefPubMedPubMedCentral
26.
Keren R, Helfand M, Homer C, McPhillips H, Lieu TA: Projected cost-effectiveness of statewide universal newborn hearing screening. Pediatrics. 2002, 110 (5): 855-864. 10.1542/peds.110.5.855.CrossRefPubMed
27.
Lieu JE, Tye-Murray N, Karzon RK, Piccirillo JF: Unilateral hearing loss is associated with worse speech-language scores in children. Pediatrics. 2010, 125 (6): e1348-e1355. 10.1542/peds.2009-2448.CrossRefPubMedPubMedCentral
28.
Mohr PE, Feldman JJ, Dunbar JL, McConkey-Robbins A, Niparko JK, Rittenhouse RK, Skinner MW: The societal costs of severe to profound hearing loss in the United States. Int J Technol Assess Health Care. 2000, 16 (4): 1120-1135. 10.1017/S0266462300103162.CrossRefPubMed
29.
Petrou S, McCann D, Law CM, Watkin PM, Worsfold S, Kennedy CR: Health status and health-related quality of life preference-based outcomes of children who are aged 7 to 9 years and have bilateral permanent childhood hearing impairment. Pediatrics. 2007, 120 (5): 1044-1052. 10.1542/peds.2007-0159.CrossRefPubMed
30.
Schroeder L, Petrou S, Kennedy C, McCann D, Law C, Watkin PM, Worsfold S, Yuen HM: The economic costs of congenital bilateral permanent childhood hearing impairment. Pediatrics. 2006, 117 (4): 1101-1112. 10.1542/peds.2005-1335.CrossRefPubMed
Metadata
Title
The cost-effectiveness of tracking newborns with bilateral hearing impairment in Bavaria: a decision-analytic model
Authors
Astrid Langer
Inken Brockow
Uta Nennstiel-Ratzel
Petra Menn
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2012
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-12-418

Other articles of this Issue 1/2012

BMC Health Services Research 1/2012 Go to the issue

Research article

A new pathway for elective surgery to reduce cancellation rates

Research article

Utilization and cost of a new model of care for managing acute knee injuries: the Calgary acute knee injury clinic

Research article

Factors affecting collaboration between general practitioners and community pharmacists: a qualitative study

Research article

An economic evaluation of adaptive e-learning devices to promote weight loss via dietary change for people with obesity

Research article

Free choice of healthcare providers in the Netherlands is both a goal in itself and a precondition: modelling the policy assumptions underlying the promotion of patient choice through documentary analysis and interviews

Research article

Persisting stigma reduces the utilisation of HIV-related care and support services in Viet Nam